Primary epithelial ovarian carcinoma in Taiwanese women

被引:0
|
作者
Wang, PH
Yuan, CC
Juang, CM
Lai, CR
Yen, MS
Chao, HT
Ng, HT
机构
[1] Vet Gen Hosp, Dept Obstet & Gynecol, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
关键词
epithelial ovarian carcinoma; multivariate and univariate analyses; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of investigation: Primary epithelial ovarian carcinoma is common in industrial countries but rare in the Orient. In fact, it is still a rare disease in Taiwan. In this article, we report the general data of Taiwanese patients with primary epithelial ovarian carcinoma. Methods: In this retrospective study we used univariate and multivariate analysis models: to analyze the prognosis of patients with surgically confirmed primary epithelial ovarian carcinoma. One hundred and ninety-four patients from 1990 to 1996 were identified and enrolled in this study. Results: The mean follow-up time was 44.7 months with an interval between 15.1 months and 105.9 months. Univariate analysis showed postmenopausal status, advanced stage, presence of lymph node metastasis, poor differentiation, and suboptimal surgery as risk factors for disease recurrence and subsequent deaths. Multivariate analysis demonstrated stage as the most important factor correlated with recurrent disease (risk ratio: 7.303 and 5.409, respectively), followed by optimal surgery (RR: 2.447), and cellular differentiation (RR: 1.677). Conclusions: Our data on the Taiwan population were consistent with other reports of different races. Early detection for primary epithelial ovarian cancer is of great importance because stage is still the most important predictor in disease-free survival and disease-related deaths. Application of the most reliable and acceptable methods of screening is our goal in the next century after weighing benefits over cents.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [1] BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma
    Wang, PH
    Shyong, WY
    Li, YF
    Lee, HH
    Tsai, WY
    Chao, HT
    Wu, CY
    Tsai, YC
    Yuan, CC
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (08) : 343 - 348
  • [2] Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer
    Eltabbakh, GH
    Piver, MS
    Natarajan, N
    Mettlin, CJ
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (02): : 254 - 259
  • [3] PRIMARY CHEMOTHERAPY OF EPITHELIAL OVARIAN-CARCINOMA
    OMURA, GA
    SILLER, BS
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1994, 10 (04): : 283 - 289
  • [4] Angiogenesis in primary and metastatic epithelial ovarian carcinoma
    Abulafia, O
    Triest, WE
    Sherer, DM
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (03) : 541 - 547
  • [5] Brain Metastases in Epithelial Ovarian and Primary Peritoneal Carcinoma
    Ratner, Elena S.
    Toy, Eugene
    O'Malley, David M.
    McAlpine, Jessica
    Rutherford, Thomas J.
    Azodi, Masoud
    Higgins, Susan A.
    Schwartz, Peter E.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 856 - 859
  • [6] EPITHELIAL OVARIAN-CARCINOMA - PRINCIPLES OF PRIMARY SURGERY
    HOSKINS, WJ
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (03) : S91 - S96
  • [7] Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma
    Goff, BA
    Paley, PJ
    Greer, BE
    Gown, AM
    [J]. GYNECOLOGIC ONCOLOGY, 2001, 81 (01) : 18 - 24
  • [8] PLASMA PREALBUMIN IN WOMEN WITH EPITHELIAL OVARIAN-CARCINOMA
    MAHLCK, CG
    GRANKVIST, K
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1994, 37 (02) : 135 - 140
  • [9] Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma
    Trimble, EL
    Christian, MC
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 3 - 4
  • [10] Ovarian epithelial borderline tumor and carcinoma in young women
    Morimura, Y
    Hoshi, K
    Watanabe, F
    Honda, T
    Yamada, H
    Sato, A
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 180 (04): : 319 - 326